G1 Therapeutics Garners $12,500,000 Series A Financing

  • Feed Type
  • Date
  • Company Name
    G1 Therapeutics
  • Mailing Address
    450 West Drive Chapel Hill, NC 27599 USA
  • Company Description
    G1 Therapeutics is working to commercialize a proprietary small molecule-based approach to protect the bone marrow from damage due to chemotherapy or radiation.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    We are excited to have MedImmune Ventures partner with Hatteras and G1 in order to accelerate the lead candidate toward clinical testing.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy